F. Bonella (Dusseldorf, Germany), A. Prasse (Freiburg, Germany)
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
A. Tzouvelekis, J. Herazo-Maya, I. Noth, X. Yang, S. F. Ma, B. Juan-Guardela, H. Lynn, G. Yu, K. Sakamoto, K. O. Lindell, K. Gibson, J. G. N. Garcia, K. Naftali (New Haven, Chicago, Pittsburgh, Tucson, United States Of America)
|   |
MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis
G. Savary, M. Buscot, E. Dewaeles, I. S. Henaoui, S. Quarré, E. Courcot, C. Cauffiez, P. Barbry, M. Perrais, B. Mari, N. Pottier (Lille, Valbonne, Nice, France)
| |
The role of CCR2+CD4+T cells in lung fibrosis
K. Milger, Y. Yu, E. Brudy, M. Irmler, M. Königshoff, F. Reichenberger, J. Behr, O. Eickelberg, S. Krauss-Etschmann (Munich, Germany)
| |
LSC 2014 abstract - M1/ M2 subpopulations of macrophages in patients with sarcoidosis- influence of smoking status
I. Osinska, D. Wolosz, T. Urbankowski, J. Domagala-Kulawik (Warsaw, Poland)
| |
Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort
Y. Pacheco, A. Calender, S. Lebecque, D. Valeyre, D. Israel-Biet, V. Cottin, P. Roy, C. Bardel, M. H. Elsensohn (Lyon, Bobigny, Paris, France)
| |
Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls
V. Vucinic-Mihailovic, Z. Sumarac, D. Jovanovic, S. Filipovic, J. Videnovic-Ivanov, B. Gvozdenovic (Beograd, Republic Of Serbia)
| |
European pulmonary alveolar proteinosis network (EuPAPNet): Results from biomarkers´ investigation
F. Bonella, I. Campo, C. H. M. van Moorsel, M. Griese, J. C. Grutters, U. Costabel, M. Luisetti (Essen, Munich, Germany; Pavia, Italy; Nieuwegein, Netherlands)
| |